Acquisition of leading cannabis company marks major milestone in InterCure's commercial expansion strategy, bringing access to premium American brands and state-of-the-art cultivation technologiesTransaction comes as Trump administration confirms it is exploring cannabis rescheduling, creating unprecedented potential opportunities for international operators like InterCureInterCure encouraged by recent regulatory momentum and positioned to capitalize on evolving U.S. cannabis landscapeNEW YORK & HERZLIYA, I ...